SBRA at a glance
Sabra Health Care REIT, Inc. (SBRA, SEC CIK 1492298) filed its latest 10-K annual report on February 12, 2026, a 10-Q quarterly report on August 3, 2026, an 8-K current report on August 3, 2026 and Form 4 insider filings as recently as September 9, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Sabra Health Care REIT, Inc. (SBRA) reported revenue of $356.9 million (up 25.4% from FY2024) and net income of $155.6 million. Diluted EPS was $0.64.
- As of June 30, 2026, 34 institutional investment managers tracked by SignalX reported holding Sabra Health Care REIT, Inc. (SBRA) shares worth $3.0 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by MATROS RICHARD K on September 8, 2026 of 200,000 shares at $20.83 per share.
- In the last 90 days, SBRA insiders reported 0 open-market purchases ($0) and 1 open-market sale ($4.2M) on Form 4, a net sale of $4.2M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $356.9M
- +25.4% vs prior year
- Insiders · 90 days
- 0 buys · 1 sell
- Net −$4.2M
- 13F holders
- 34 funds
- $3.0B · +0 vs prior quarter
- Latest 8-K
- Aug 3, 2026
- Item 2.02 · Item 7.01
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Core business model: Real estate investment trust focusing on healthcare properties with skilled nursing, senior housing, and specialty hospitals
- Emphasis on occupancy trends with skilled nursing occupancy increasing to 83.4% in 2025 from 76.4% in 2023
- Senior Housing - Leased occupancy stable near 89%, while Behavioral Health occupancy declined to 76.5% in 2025 from 80.7% in 2023
- Facility financial data derived solely from tenants/operators, no independent verification by Sabra
- Occupancy data used cautiously, excluding non-stabilized properties and reflecting only facilities owned at each period end
Risk Factors
- Regulatory risk: heightened enforcement of Medicare and Medicaid rules increasing inspections, citations, and penalties affecting tenants' operations and reimbursement
- Macroeconomic threat: inflation increasing operating and capital expenses faster than rental income, pressuring profitability of Senior Housing - Managed communities
- Supply chain vulnerability: labor shortages and wage inflation forcing tenants and operators to raise pay or use costly contract staff, impacting cash flows
- Competitive risk: competition from larger REITs, private equity, hedge funds, and alternatives like home health services reducing occupancy and rents
- Financial risk: dependency on CEO Mr. Matros, loss of whom could impair management and strategic execution
Management Discussion & Analysis
- Revenue $774.6M in 2025, up 8% YoY from $703.1M; rental revenues down $7.4M, resident fees up $72.3M, interest income up $6.5M
- Operating margin not explicitly stated; depreciation up 10% to $187.0M, interest expense down 2% to $112.5M, senior housing operating expenses up 22% to $256.6M
- Best segment: Senior Housing - Managed revenue $356.9M, +25% YoY; Worst segment: triple-net rental revenues $374.1M, -2% YoY
- Net cash provided by operating activities $348.6M; investing cash outflows $378.0M for acquisitions and additions; financing cash inflows $40.8M including $500M term loan proceeds; dividends paid $289.5M
- $1.2B liquidity as of Dec 31, 2025 including $71.5M cash and $782.4M available revolver; management expects sufficient cash flow and credit availability for next 12 months; redeemed $500M 2026 notes in July 2025
AI summary of the SBRA 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Quarterly revenue $235.9M, up $46.7M or 25% YoY, driven by resident fees and services
- Resident fees and services strongest line at $128.8M, up $49.8M or 63% YoY
- Loan-loss provision $102.4M versus $0.2M recovery YoY, primarily tied to Recovery Centers of America repayment
- Acquisitions totaled $287.6M during six months; dispositions generated $37.7M quarterly net real-estate gains
- Headwinds: inflation, higher operating expenses, capital-market volatility, tenant and borrower default risks
Risk Factors
- No risk-factor section provided; only insider-trading disclosure and exhibits
- Executive share-sale risk: Rule 10b5-1 Plan covers potential sale of 200,000 shares
- Market signaling risk: CEO’s planned sales commence September 8, 2026
- Governance disclosure: Plan terminates March 10, 2027 or when all shares sell
AI summary of the SBRA 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Sabra reported second-quarter 2026 results for the three months ended June 30, 2026
- Press release furnished as Exhibit 99.1, with non-GAAP reconciliations in Exhibit 99.3
Item 7.01: Regulation FD Disclosure
- Supplemental information package furnished as Exhibit 99.2 and available on Sabra’s investor website
- Exhibit 99.4 presentation materials intended for investor presentations
Item EX-99.1: Item EX-99.1
- Q2 normalized FFO $0.38 and normalized AFFO $0.40 per share, supporting the $0.30 quarterly dividend
- GAAP net loss $(0.10) per share, driven by a $102.4M provision for loan losses and other reserves
Item 7.01: Regulation FD Disclosure
- Sabra furnished a press release under Regulation FD as Exhibit 99.1
- Investor-relevant details reside in the attached press release
Item 5.07: Submission of Matters to a Vote of Security Holders
- Seven director nominees elected, preserving board continuity through the 2027 annual meeting
- PwC appointment ratified for fiscal 2026, supporting auditor continuity
AI summaries of SBRA 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for SBRA
Don't miss the next SBRA filing
- Alerts as it files. A push when SBRA files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut SBRA, by share count.
- Ask anything. An AI agent that reads every SBRA filing and answers with sources.
SBRA alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| MATROS RICHARD K | Sell | Sep 8, 2026 | 200,000 | $20.83 |
| Cusack Catherine | A | Aug 31, 2026 | 791 | - |
| Costa Michael Lourenco | A | Aug 31, 2026 | 4,158 | - |
| Malehorn Jeffrey A. | A | Aug 31, 2026 | 791 | - |
| Smith Darrin | A | Aug 31, 2026 | 495 | - |
| FLORES JESSICA | A | Aug 31, 2026 | 382 | - |
| Barbarosh Craig A. | A | Aug 31, 2026 | 791 | - |
| Kono Ann | A | Aug 31, 2026 | 791 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $236.2M | $284.6M | $356.9M | |
| Net Income | $13.8M | $126.7M | $155.6M | |
| Net Margin | 5.8% | 44.5% | 43.6% | |
| Balance Sheet | ||||
| Total Assets | $5.4B | $5.3B | $5.5B | |
| Equity | $2.8B | $2.7B | $2.8B | |
| ROE | 0.5% | 4.6% | 5.5% | |
| Per Share | ||||
| EPS | $0.06 | $0.54 | $0.64 | |
| Cash Flow | ||||
| Operating CF | $300.6M | $310.5M | $348.6M | |
Source: XBRL data in Sabra Health Care REIT, Inc. (SBRA)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate SBRA share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 34 | $3.01B |
| Q1 2026 | 34 | $3.02B |
| Q4 2025 | 32 | $2.81B |
| Q3 2025 | 32 | $2.71B |
| Q2 2025 | 30 | $2.58B |
| Q1 2025 | 28 | $1.80B |
| Q4 2024 | 24 | $1.57B |
| Q3 2024 | 22 | $982.9M |
- BlackRock+2.52M (+6%)
- Citigroup+941.6K (+289%)
- AQR Capital Management+584.9K (+41%)
- Invesco Ltd+210.9K (+9%)
- Vanguard Portfolio Management LLC+209.1K (+1%)
- JPMorgan Chase & Co−4.97M (-61%)
- Millennium Management−838.8K (-53%)
- Two Sigma Investments−560.5K (-22%)
- FMR LLC (Fidelity)−446.8K (-13%)
- Principal Financial Group−346.1K (-1%)
Source: 13F-HR filings on SEC EDGAR (aggregated from 236 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
SBRA filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Sep 9, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 4 | Sep 2, 2026 | - | - | - |
| 8-K | Aug 3, 2026 | - | Analysis | - |
| 10-Q | Aug 3, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Jul 21, 2026 | - | Analysis | - |
| 4 | Jun 18, 2026 | - | - | - |
| 4 | Jun 18, 2026 | - | - | - |
| 4 | Jun 18, 2026 | - | - | - |
| 4 | Jun 18, 2026 | - | - | - |
| 4 | Jun 18, 2026 | - | - | - |
| 4 | Jun 18, 2026 | - | - | - |
| 8-K | Jun 17, 2026 | - | Analysis | - |
| 4 | Jun 2, 2026 | - | - | |
| 4 | Jun 2, 2026 | - | - | |
| 4 | Jun 2, 2026 | - | - | |
| 4 | Jun 2, 2026 | - | - |
Related Real Estate companies
- AKR · ACADIA REALTY TRUSTReal Estate Investment Trusts
- ACR · ACRES Commercial Realty Corp.Real Estate Investment Trusts
- ADAM · ADAMAS TRUST, INC.Real Estate Investment Trusts
- ALX · ALEXANDERS INCReal Estate Investment Trusts
- ARE · Alexandria Real Estate EquitiesReal Estate Investment Trusts
- PINE · Alpine Income Property Trust, Inc.Real Estate Investment Trusts
- AAT · American Assets Trust, Inc.Real Estate Investment Trusts
- AHR · American Healthcare REIT, Inc.Real Estate Investment Trusts
SBRA SEC filings: frequently asked questions
Are SBRA insiders buying or selling?
In the last 90 days, Sabra Health Care REIT, Inc. (SBRA) officers, directors and 10% owners reported no open-market purchases and 1 open-market sale worth $4.2 million by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold SBRA stock?
As of June 30, 2026, the largest Sabra Health Care REIT, Inc. (SBRA) holders among the 13F filers tracked by SignalX were BlackRock ($811.9 million), Principal Financial Group ($482.0 million), Vanguard Portfolio Management LLC ($455.6 million), State Street Corp ($240.1 million), Vanguard Capital Management LLC ($221.4 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was SBRA's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Sabra Health Care REIT, Inc. (SBRA) reported revenue of $356.9 million (up 25.4% from FY2024) and net income of $155.6 million. Diluted EPS was $0.64. The figures come from the XBRL data in the 10-K.
What are the main risks in SBRA's latest 10-K?
In the 10-K filed February 12, 2026, Sabra Health Care REIT, Inc. (SBRA) flagged: Regulatory risk: heightened enforcement of Medicare and Medicaid rules increasing inspections, citations, and penalties affecting tenants' operations and reimbursement. Macroeconomic threat: inflation increasing operating and capital expenses faster than rental income, pressuring profitability of Senior Housing - Managed communities. (AI summary of the Risk Factors section.)
What did SBRA report in its latest 8-K?
Sabra Health Care REIT, Inc. (SBRA) filed an 8-K on August 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). Sabra reported second-quarter 2026 results for the three months ended June 30, 2026.
What are the latest SBRA SEC filings?
Sabra Health Care REIT, Inc. (SBRA) filed its latest 10-K annual report on February 12, 2026, a 10-Q quarterly report on August 3, 2026, an 8-K current report on August 3, 2026 and a Form 4 insider filing on September 9, 2026.
What is SBRA's SEC CIK number?
Sabra Health Care REIT, Inc. (SBRA)'s SEC Central Index Key (CIK) is 1492298. EDGAR lists every SBRA filing under that number.
Ask anything about SBRA
The research agent reads SBRA's filings, financials, insider trades and 13F holders, then answers with sources.